APA (7th ed.) Citation

DH, K., YI, J., CW, C., CH, K., TW, K., HM, L., & DH, K. (2013). Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells. Dove Medical Press.

Chicago Style (17th ed.) Citation

DH, Kim, Jeong YI, Chung CW, Kim CH, Kwak TW, Lee HM, and Kang DH. Preclinical Evaluation of Sorafenib-eluting Stent for Suppression of Human Cholangiocarcinoma Cells. Dove Medical Press, 2013.

MLA (8th ed.) Citation

DH, Kim, et al. Preclinical Evaluation of Sorafenib-eluting Stent for Suppression of Human Cholangiocarcinoma Cells. Dove Medical Press, 2013.